Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950146-98-000305
Filing Date
1998-02-27
Accepted
1998-02-27 00:00:00
Documents
6
Period of Report
1997-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT 10-K 213713
2 RIGHTS AGREEMENT EX-4.2 111521
3 DEFERRED COMPENSATION PLAN EX-10.13 14857
4 VARIABLE COMPENSATION PLAN EX-10.16 10267
5 CONSENT OF INDEPENDENT ACCOUNTANTS EX-23 488
6 FDS EX-27 2572
  Complete submission text file 0000950146-98-000305.txt   355494
Mailing Address CORNING PHARMACEUTICAL SERVICES INC 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address 210 CARNEGIE CENTER PRINCETON NJ 08540 6094528550
COVANCE INC (Filer) CIK: 0001023131 (see all company filings)

EIN.: 223265977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12213 | Film No.: 98552456
SIC: 8731 Services-Commercial Physical & Biological Research